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TO THE EDITOR
Atopic dermatitis (AD) is a common
chronic inflammatory skin disease.
The pathophysiological factors include
genetic predisposition to skin-barrier
defects, dysregulated immunity, and
hypersensitive allergen response
(Novak and Simon, 2011). The high
levels of proinflammatory cytokines in
AD initiate and maintain the inflam-
mation (Bieber, 2008) and mediate
cross-talk between innate and adaptive
immune systems. The recently described
cytosolic receptors of the nucleotide-
binding domain and leucine-rich
repeat (NLR)–containing family have
been shown to have a key role in
innate immune regulation. The NLR
family pyrin domain–containing pro-
teins (NLRPs) are recognized for forming
a multiprotein complex referred to as
the ‘‘inflammasome’’, which activates
the proinflammatory cytokines, interleu-
kin (IL)-1b, -18, and -33 (Li et al., 2008).
The above ILs are important in innate
immune functions and in the regulation
of adaptive immunity. Single-nucleotide
polymorphisms (SNPs) in NLRP1 have
been associated with vitiligo and related
autoimmune conditions (Jin et al.,
2007a,b), whereas SNPs in NLRP3
have been associated with food anaphy-
laxis and allergic asthma (Hitomi et al.,
2009), rheumatoid arthritis (Kastbom
et al., 2008), Crohn’s disease (Schoultz
et al., 2009; Villani et al., 2009), and
malignant melanoma (Verma et al.,
2012). As atopic manifestations, e.g.,
food allergies, asthma, allergic rhinitis,
and allergic conjunctivitis, are common,
we investigate the significance of seven
SNPs located in three different
inflammasome genes (NLRP1, NLRP3,
and CARD8) in the susceptibility of AD.
All of the studied SNPs except those
in NLRP1 are demonstrated to be of
functional significance.
A Swedish AD family material
(Bradley et al., 2000) including 1,708
individuals (1,260 affected) from 494
families with at least two affected
siblings were included in the analysis.
Measurements of total serum-IgE con-
centrations and IgE-specific antibodies
for food and inhalant allergens were
performed (Bradley et al., 2000). A
Swedish control population without
eczema comprising 732 healthy indivi-
duals was analyzed as the reference
population. We performed TaqMan
genotyping for variants of NLRP1
(rs6502867 and rs12150220), NLRP3
(rs35829419, rs10733113, rs10754558,
and rs4612666), and CARD8
(rs2043211) using an ABI Prism 7500
Sequence Detection System, with the
SDS 2.3 software for allelic discri-
mination (Applied Biosystems, Foster
City, CA). None of the SNPs were in
linkage disequilibrium (r2p0.3).
A pedigree disequilibrium test (PDT)
was carried out to investigate evidence
for the association between the genetic
variants and AD. Data for the family-
based association analysis, including
odds ratio (OR), 95% confidence
interval, and correction for multiple
testing (10.000 permutations), were cal-
culated using the UNPHASED program
(v.3.1.4, http://unphased.sourceforge.net).
All SNPs were shown to be in Hardy–
Weinberg equilibrium in the control
population. No statistical associations
between variants and AD were found
either overall or after stratification for
different phenotypes (Supplementary
Table S1a online). As gender-specific
associations have previously been
reported for NLRP3 SNPs (Schoultz
et al., 2009), we further stratified for
gender. The results showed a signifi-
cant association between NLRP3Accepted article preview online 5 April 2013; published online 16 May 2013
Abbreviations: AD, atopic dermatitis; CI, confidence interval; IL, interleukin; NLR, nucleotide-binding
domain and leucine-rich repeat; NLRP, NLR family pyrin domain–containing protein; OR, odds ratio; PDT,
pedigree disequilibrium test; SNP, single-nucleotide polymorphism
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variant rs10733113 and raised total IgE
antibodies among male individuals (OR
0.44(0.25–0.77), P¼ 0.02 corrected)
(Table 1, Supplementary Table S1b
online). No association among female
individuals was found (Supplementary
Table S1c online). This NLRP3 SNP has
previously been implicated in Crohn’s
disease (Villani et al., 2009), and
the NLRP3 SNPs rs4612666 and
rs10754558 have been associated
with food-induced anaphylaxis and
aspirin-induced asthma in a Japanese
case–control study (Hitomi et al.,
2009). However, we did not detect any
AD association with these SNPs in our
population.
In a separate study design, we
included one randomly selected AD
patient from each family, resulting in
454 patients, and compared them with
732 healthy Swedish controls from the
same geographical area. Comparison
between cases and controls was per-
formed using logistic regression analysis
and STATA v.10 statistical package
(www.stata.com). P-values o0.05 were
subjected to Bonferroni’s correction.
The commonly occurring NLRP1 SNP
rs12150220 revealed a strong associa-
tion in overall comparison, also follow-
ing corrections for multiple testing
(OR 0.54 (0.39–0.76), P¼0.0001,
P¼0.0021 corrected, Table 2), indicat-
ing a role in AD susceptibility. Upon
gender stratification, associations were
found for both sexes, most prominent
among male individuals (OR 0.45
(0.27–0.76), P¼ 0.003) compared with
female individuals (OR 0.61 (0.39–
0.96), P¼ 0.033). However, only
borderline significance among male
individuals remained after Bonferroni
correction (P¼0.063). This missense-
coding SNP (Leu155His), owing to its
localization between PYRIN and
NACHT domains of NLRP1, might have
an important function during oligomer-
ization with other proteins. The con-
sequence of this allelic variant was
analyzed by Polyphen and was pre-
dicted to be ‘‘probably functionally
damaging’’. Furthermore, the SNP is
located in a highly conserved region
through primate evolution (Jin et al.,
2007b), indicating this region to be
critical for the NLRP1 function.
Moreover, the CARD8 SNP rs2043211,
a suggested binding partner in the
NLRP3 inflammasome and inhibitor
of NFkB activity, was found to be
associated with AD among female
individuals (OR 0.55 (0.32–0.95),
P¼ 0.033), but not following correction.
This SNP has previously been shown to
be associated with rheumatoid arthritis
(Kastbom et al., 2010) and, in combi-
nation with NLRP3 variant rs35829419,
with Crohn’s disease (Roberts et al.,
2010). Interestingly, CARD8 interacts
with NOD2 that has been associated
with atopic traits (Kabesch et al., 2003).
Interaction analyses of rs10733113
and rs12150220, which showed
Table 1. Results of pedigree disequilibrium test for NLRP3 rs10733113
variant in families with AD
P-value N affected OR (95% CI)
AD/Williams1
AD 0.50 1,260 0.93 (0.76–1.15)
Males 0.27 450 0.83 (0.61–1.14)
Females 0.85 723 0.97 (0.75–1.26)
ADþ specific IgE
AD 0.64 669 0.94 (0.73–1.21)
Males 0.34 297 0.84 (0.58–1.20)
Females 0.95 372 0.99 (0.71–1.38)
Early onset of AD 2
AD 0.58 881 0.94 (0.74–1.19)
Males 0.25 348 0.81 (0.57–0.16)
Females 0.94 533 1.01 (0.76–1.34)
Severe AD 3
AD 0.53 483 0.91 (0.68–1.22)
Males 0.18 210 0.74 (0.48–1.15)
Females 0.86 273 0.97 (0.67–1.40)
ADþ asthma
AD 0.64 611 0.94 (0.73–1.20)
Males 0.34 269 0.84 (0.58–1.2)
Females 0.95 342 0.99 (0.71–1.38)
ADþ rhinoconj 4
AD 0.80 851 0.97 (0.77–1.23)
Males 0.21 343 0.79 (0.55–1.12)
Females 0.62 508 1.09 (0.78–1.52)
ADþ raised total IgE
AD 0.03 355 0.71 (0.52–0.98)
Males 0.0025 137 0.44 (0.25–0.77)
Females 0.53 218 0.88 (0.58–1.33)
ADþ food allergy
AD 0.04 215 0.65 (0.43–1.00)
Males 0.04 96 0.52 (0.26–1.03)
Females 0.14 119 0.67 (0.38–1.16)
Abbreviations: AD, atopic dermatitis; CI, confidence interval; OR, odds ratio.
1AD based on clinical examination according to the UK Working Party’s Diagnostic Criteria.
2p2 Years.
3Severity scoring X4.
4ADþ rhinoconjunctivitis.
5Corrected P-value 0.02.
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significant associations with AD in this
study, did not reach overall significant
association in the pedigree approach
(P¼ 0.81, 0.91 (0.64–1.30)) nor streng-
then the association in the case–control
design (P¼0.017, 0.62 (0.42–0.92)). No
further changes were noted after gender
stratifications.
Genome-wide association studies in
AD have failed to identify studied
chromosomal regions (Hirota et al.,
2012; Paternoster et al., 2012), but this
does not entirely exclude the signifi-
cance of these genes. The SNPs were
selected as disease associations have
already been reported for each of them
in other relevant inflammatory condi-
tions. Inflammasomes have emerged
as promising candidates for different
skin pathologies, and the inflammatory
cytokines IL-1b and IL-18 are key
molecules orchestrating atopic skin
inflammation (Homey, 2006). A critical
role for an additional inflammatory
cytokine IL-33 in AD has recently been
reported (Savinko et al., 2012), and
SNPs in IL-33, IL-33R, and IL-18R are
of potential interest in this regard
(Akhabir and Sandford, 2010). In this
large and comprehensive study, we
have analyzed seven commonly occurr-
ing inflammasome SNPs using two study
designs: a family-based PDT analysis
comprising 1,708 individuals and a
case–control design comprising 454
cases and 732 controls. One limitation
of case–control studies, the most com-
monly used approach for SNP associa-
tion studies, is the sensitiveness to
population stratifications. The family-
based design is more robust to con-
founding factors and variance due to
the common genetic background among
the family members. However, PDTs
require more patients to detect the same
level of association as case–control stu-
dies. NLRP1 rs12150220 displayed
strong associations with overall suscept-
ibility to AD using the case–control
design, which, however, could not be
confirmed in the PDT analysis, prompt-
ing a cautious interpretation of our
results. The associated risk is probably
quite modest, and NLRP1 might be one
of the several factors, demanding an
additional triggering risk locus/factor.
The role of rare susceptibility variants
cannot be ruled out, although their
contribution to the disease might be
limited. However, to confirm the rele-
vance of these NLRP SNPs and AD,
additional cohorts are warranted.
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Table 2. Genetic association of NLRP3, NLRP1, and CARD8 variants with
AD in cases and controls
P-value Controls Cases OR (95% CI)
NLRP3
rs35829419
AD 0.704 732 454 1.29 (0.34–4.84)
Males 0.332 370 178 2.22 (0.44–11.13)
Females 0.698 361 276 0.62 (0.056–6.89)
rs10733113
AD 0.427 732 441 1.39 (0.62–3.14)
Males 0.258 370 166 1.90 (0.62–5.77)
Females 0.899 361 275 1.08 (0.33–3.59)
rs10754558
AD 0.363 684 452 1.18 (0.83–1.69)
Males 0.192 342 177 1.45 (0.83–2.54)
Females 0.877 341 275 0.96 (0.60–1.54)
rs4612666
AD 0.872 687 420 1.04 (0.67–1.61)
Males 0.759 344 164 1.11 (0.57–2.18)
Females 0.942 342 256 0.98 (0.54–1.76)
NLRP1
rs6502867
AD 0.147 724 435 1.46 (0.88–2.42)
Males 0.116 366 172 1.95 (0.85–4.50)
Females 0.697 357 263 1.14 (0.60–2.16)
rs12150220
AD 0.00011 730 436 0.54 (0.39–0.76)
Males 0.0032 368 174 0.45 (0.27–0.76)
Females 0.0333 361 262 0.61 (0.39–0.96)
CARD8
rs2043211
AD 0.321 732 452 0.82 (0.56–1.21)
Males 0.334 370 177 1.31 (0.76–2.27)
Females 0.0334 361 275 0.55 (0.32–0.95)
Abbreviations: AD, atopic dermatitis; CI, confidence interval; OR, odds ratio.
Corrected P-values.
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TO THE EDITOR
Chronic pruritus affects millions of
patients worldwide and has a significant
impact on quality of life similar to
that of chronic pain (Sta¨nder et al.,
2007; Kini et al., 2011). Significant
advances have been made in the past
5 years to elucidate the molecular
pathways of acute itch (Sun and Chen,
2007; Liu et al., 2009). However,
experimental approaches investigating
the pathogenesis of pruritus and the
ability to test novel therapeutic agents
are largely limited to rodent models.
Although these models offer some
advantages, their translational potential
to human disease remains to be establi-
shed (Jeffry et al., 2011; Seok et al.,
2013). Furthermore, most animal models
focus on acute itch, which displays sig-
nificant pathophysiological differences
in comparison with chronic itch
(Yosipovitch et al., 2007). Therefore,
there is an unmet need for better
animal models for chronic itch research.
Recently, gastrin-releasing peptide
(GRP) and its receptor (GRPR) were
discovered to have a key role in itch
transmission, but not in nociception
(Sun and Chen, 2007). GRP was found
in a subset of unmyelinated dorsal root
ganglion neurons, whereas GRPR was
expressed in lamina I of the dorsal horn
of the spinal cord in mice. In the skin,
GRP is present in primary afferent nerve
fibers and is found to be increased in
mice with chronic dermatitis (Tominaga
et al., 2009). The GRP/GRPR signaling
pathway is considered to be the first
molecular pathway specific to itch
transmission, but there is no evidence
that this pathway has an analogous role
in primates or humans.
We identified a subgroup of adult
female Cynomolgus macaques (Macaca
fascicularis) suffering from idiopathic
chronic itch and observed theirAccepted article preview online 4 April 2013; published online 9 May 2013
Abbreviations: GRP, gastrin-releasing peptide; GRPR, gastrin-releasing peptide receptor; PGP9.5, product
gene protein 9.5
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